_id
690db555ccc777a4e85d0db0
Ticker
BBLG
Name
Bone Biologics Corp
Exchange
NASDAQ
Address
2 Burlington Woods Drive, Burlington, MA, United States, 01803
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.bonebiologics.com
Description
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company's NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Last Close
1.76
Volume
10564
Current Price
1.755
Change
-0.025
Last Updated
2026-01-20T16:15:38.934Z
Image
data:image/webp;base64,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
Ipo Date
2016-03-31T00:00:00.000Z
Market Cap
3195562
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.99
Sentiment Sources
1
Rating
5
Target Price
22.25
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
715274
Operating Income
-715274
Interest Expense
-
Pretax Income
-666737
Net Income
-666737
Eps
-0.37142115440001294
Dividends Per Share
-
Shares Outstanding
1795260
Income Tax Expense
-
EBITDA
48537
Operating Margin
-
Total Other Income Expense Net
48537
Cash
6049084
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
6350799
Property Plant Equipment
-
Total Assets
6350799
Payables
333081
Short Term Debt
-
Long Term Debt
-
Total Liabilities
334282
Equity
6016517
Bs_currency_symbol
USD
Depreciation
715274
Change In Working Capital
60033
Cash From Operations
-591384
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-591384
Cf_currency_symbol
USD
PE
-
PB
0.5236244217376931
ROE
-11.081777048082802
ROA
-10.498474286463798
FCF
-591384
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
7
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
715274
Quarters > 0 > income Statement > operating Income
-715274
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-666737
Quarters > 0 > income Statement > net Income
-666737
Quarters > 0 > income Statement > eps
-0.37142115440001294
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1795097
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
48537
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
48537
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
6049084
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
6350799
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
6350799
Quarters > 0 > balance Sheet > payables
333081
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
334282
Quarters > 0 > balance Sheet > equity
6016517
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-666737
Quarters > 0 > cash Flow > depreciation
715274
Quarters > 0 > cash Flow > change In Working Capital
60033
Quarters > 0 > cash Flow > cash From Operations
-591384
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-591384
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.37142115440001294
Quarters > 0 > ratios > PB
0.5236244217376931
Quarters > 0 > ratios > ROE
-11.081777048082802
Quarters > 0 > ratios > ROA
-10.498474286463798
Quarters > 0 > ratios > FCF
-591384
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
748075
Quarters > 1 > income Statement > operating Income
-748075
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-740519
Quarters > 1 > income Statement > net Income
-740519
Quarters > 1 > income Statement > eps
-1.3276017547917036
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
557787
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-748075
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
7556
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
6640468
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
7002216
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
7002216
Quarters > 1 > balance Sheet > payables
403729
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
406142
Quarters > 1 > balance Sheet > equity
6596074
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-740519
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
209643
Quarters > 1 > cash Flow > cash From Operations
-458879
Quarters > 1 > cash Flow > capital Expenditures
5
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
4352792
Quarters > 1 > cash Flow > net Change In Cash
3893913
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-1.3276017547917036
Quarters > 1 > ratios > PB
0.14840891490908076
Quarters > 1 > ratios > ROE
-11.226663011967423
Quarters > 1 > ratios > ROA
-10.57549495759628
Quarters > 1 > ratios > FCF
-458884
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1038486
Quarters > 2 > income Statement > operating Income
-1038486
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1017092
Quarters > 2 > income Statement > net Income
-1017092
Quarters > 2 > income Statement > eps
-0.31953879987433237
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
3183000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-1017092
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
21393
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2746555
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3162060
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
3162060
Quarters > 2 > balance Sheet > payables
247843
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
251158
Quarters > 2 > balance Sheet > equity
2910902
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1017092
Quarters > 2 > cash Flow > depreciation
1038486
Quarters > 2 > cash Flow > change In Working Capital
41717
Quarters > 2 > cash Flow > cash From Operations
-926125
Quarters > 2 > cash Flow > capital Expenditures
5
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
347549
Quarters > 2 > cash Flow > net Change In Cash
-578576
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.31953879987433237
Quarters > 2 > ratios > PB
1.9190494905015696
Quarters > 2 > ratios > ROE
-34.94078467773907
Quarters > 2 > ratios > ROA
-32.165487055906596
Quarters > 2 > ratios > FCF
-926130
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
43
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
1554938
Quarters > 3 > income Statement > operating Income
-1554938
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-1521715
Quarters > 3 > income Statement > net Income
-1521715
Quarters > 3 > income Statement > eps
-0.5151371022342587
Quarters > 3 > income Statement > dividends Per Share
3212504
Quarters > 3 > income Statement > shares Outstanding
2954000
Quarters > 3 > income Statement > income Tax Expense
903536
Quarters > 3 > income Statement > EBITDA
-1521715
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
33223
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3325131
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3861369
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
3861369
Quarters > 3 > balance Sheet > payables
373042
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
377712
Quarters > 3 > balance Sheet > equity
3483657
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-1521715
Quarters > 3 > cash Flow > depreciation
-904000
Quarters > 3 > cash Flow > change In Working Capital
80423
Quarters > 3 > cash Flow > cash From Operations
-1353497
Quarters > 3 > cash Flow > capital Expenditures
3
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1112202
Quarters > 3 > cash Flow > net Change In Cash
-241295
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.5151371022342587
Quarters > 3 > ratios > PB
1.4881688983731751
Quarters > 3 > ratios > ROE
-43.68153925601745
Quarters > 3 > ratios > ROA
-39.40869158062853
Quarters > 3 > ratios > FCF
-1353500
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
4219000
Annuals > 0 > income Statement > operating Income
-4219000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-4112420
Annuals > 0 > income Statement > net Income
-4112000
Annuals > 0 > income Statement > eps
-2.7106130520764666
Annuals > 0 > income Statement > dividends Per Share
3212504
Annuals > 0 > income Statement > shares Outstanding
1517000
Annuals > 0 > income Statement > income Tax Expense
-7324924
Annuals > 0 > income Statement > EBITDA
107161
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
106741
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
3325131
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
3861369
Annuals > 0 > balance Sheet > property Plant Equipment
-
Annuals > 0 > balance Sheet > total Assets
3861369
Annuals > 0 > balance Sheet > payables
373042
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
377712
Annuals > 0 > balance Sheet > equity
3483657
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-4112420
Annuals > 0 > cash Flow > depreciation
4219161
Annuals > 0 > cash Flow > change In Working Capital
-150253
Annuals > 0 > cash Flow > cash From Operations
-4124935
Annuals > 0 > cash Flow > capital Expenditures
5
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
4423497
Annuals > 0 > cash Flow > net Change In Cash
298562
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-2.7106130520764666
Annuals > 0 > ratios > PB
0.7642356868084315
Annuals > 0 > ratios > ROE
-118.0368790612853
Annuals > 0 > ratios > ROA
-106.49072906526158
Annuals > 0 > ratios > FCF
-4124940
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
0
Annuals > 1 > income Statement > operating Expenses
9428000
Annuals > 1 > income Statement > operating Income
-9428000
Annuals > 1 > income Statement > interest Expense
2180553
Annuals > 1 > income Statement > pretax Income
-8949000
Annuals > 1 > income Statement > net Income
-8949000
Annuals > 1 > income Statement > eps
-34.00890030668435
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
263137
Annuals > 1 > income Statement > income Tax Expense
-2180553
Annuals > 1 > income Statement > EBITDA
479572
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
479572
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3026569
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
328844
Annuals > 1 > balance Sheet > inventories
-579910
Annuals > 1 > balance Sheet > total Current Assets
3737763
Annuals > 1 > balance Sheet > property Plant Equipment
-
Annuals > 1 > balance Sheet > total Assets
3737763
Annuals > 1 > balance Sheet > payables
360662
Annuals > 1 > balance Sheet > short Term Debt
-783674.46
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
831402
Annuals > 1 > balance Sheet > equity
2906361
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-8948731
Annuals > 1 > cash Flow > depreciation
9428000
Annuals > 1 > cash Flow > change In Working Capital
132921
Annuals > 1 > cash Flow > cash From Operations
-9555904
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
5044161
Annuals > 1 > cash Flow > net Change In Cash
-4511743
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-34.00890030668435
Annuals > 1 > ratios > PB
0.15889472608530048
Annuals > 1 > ratios > ROE
-307.91082043834194
Annuals > 1 > ratios > ROA
-239.42127951932747
Annuals > 1 > ratios > FCF
-9555904
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
3665173
Annuals > 2 > income Statement > operating Income
-3665173
Annuals > 2 > income Statement > interest Expense
731714
Annuals > 2 > income Statement > pretax Income
-1484620
Annuals > 2 > income Statement > net Income
-1484620
Annuals > 2 > income Statement > eps
-31.192116984620558
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
47596
Annuals > 2 > income Statement > income Tax Expense
-2181000
Annuals > 2 > income Statement > EBITDA
-752906
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
2180553
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
7538312
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
579910
Annuals > 2 > balance Sheet > inventories
-579910
Annuals > 2 > balance Sheet > total Current Assets
8495237
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
8495237
Annuals > 2 > balance Sheet > payables
888.46
Annuals > 2 > balance Sheet > short Term Debt
783674.46
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2547929
Annuals > 2 > balance Sheet > equity
5947308
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-1484620
Annuals > 2 > cash Flow > depreciation
3665000
Annuals > 2 > cash Flow > change In Working Capital
-168373
Annuals > 2 > cash Flow > cash From Operations
-3566913
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
4429860
Annuals > 2 > cash Flow > net Change In Cash
862947
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-31.192116984620558
Annuals > 2 > ratios > PB
0.014045174724429942
Annuals > 2 > ratios > ROE
-24.96289077343901
Annuals > 2 > ratios > ROA
-17.475910324809067
Annuals > 2 > ratios > FCF
-3566913
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
0
Annuals > 3 > income Statement > operating Expenses
1101476
Annuals > 3 > income Statement > operating Income
-1101476
Annuals > 3 > income Statement > interest Expense
805109
Annuals > 3 > income Statement > pretax Income
-1609085
Annuals > 3 > income Statement > net Income
-1610685
Annuals > 3 > income Statement > eps
-37.3474853340135
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
43127
Annuals > 3 > income Statement > income Tax Expense
1600
Annuals > 3 > income Statement > EBITDA
-803976
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-507609
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
6675365
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
6675365
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
6675365
Annuals > 3 > balance Sheet > payables
99909
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
99909
Annuals > 3 > balance Sheet > equity
6575456
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1610685
Annuals > 3 > cash Flow > depreciation
297500
Annuals > 3 > cash Flow > change In Working Capital
-320487
Annuals > 3 > cash Flow > cash From Operations
-1228586
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
7903951
Annuals > 3 > cash Flow > net Change In Cash
6675365
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-37.3474853340135
Annuals > 3 > ratios > PB
0.011510667092898197
Annuals > 3 > ratios > ROE
-24.495411420896133
Annuals > 3 > ratios > ROA
-24.128792957388846
Annuals > 3 > ratios > FCF
-1228586
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.37142115440001294
Valuation > metrics > PB
0.5236244217376931
Valuation > final Score
70
Valuation > verdict
47.6% Undervalued
Profitability > metrics > ROE
-11.081777048082802
Profitability > metrics > ROA
-10.498474286463798
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.055560717272136025
Risk > metrics > Interest Coverage
-1
Risk > final Score
56
Risk > verdict
High
Liquidity > metrics > Current Ratio
19.066830590757203
Liquidity > metrics > Quick Ratio
19.066830590757203
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-336
Prev Risks > 1
80
Prev Risks > 2
80
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:27:37.396Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-14
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.37
Earnings History > 0 > eps Estimate
-7.92
Earnings History > 0 > eps Difference
7.55
Earnings History > 0 > surprise Percent
95.3283
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.33
Earnings History > 1 > eps Estimate
-0.58
Earnings History > 1 > eps Difference
-0.75
Earnings History > 1 > surprise Percent
-129.3103
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.3195
Earnings History > 2 > eps Estimate
-7.68
Earnings History > 2 > eps Difference
7.3605
Earnings History > 2 > surprise Percent
95.8398
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-26
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-2.88
Earnings History > 3 > eps Estimate
-3.9
Earnings History > 3 > eps Difference
1.02
Earnings History > 3 > surprise Percent
26.1538
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-14.22
Earnings History > 4 > eps Estimate
-3.6
Earnings History > 4 > eps Difference
-10.62
Earnings History > 4 > surprise Percent
-295
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.67
Earnings History > 5 > eps Estimate
-1.39
Earnings History > 5 > eps Difference
0.72
Earnings History > 5 > surprise Percent
51.7986
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.31
Earnings History > 6 > eps Estimate
-7.6
Earnings History > 6 > eps Difference
6.29
Earnings History > 6 > surprise Percent
82.7632
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-20
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-2.47
Earnings History > 7 > eps Estimate
-5.6
Earnings History > 7 > eps Difference
3.13
Earnings History > 7 > surprise Percent
55.8929
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.61
Earnings History > 8 > eps Estimate
-3.04
Earnings History > 8 > eps Difference
2.43
Earnings History > 8 > surprise Percent
79.9342
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.48
Earnings History > 9 > eps Estimate
-1.5
Earnings History > 9 > eps Difference
1.02
Earnings History > 9 > surprise Percent
68
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-15
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-6.9
Earnings History > 10 > eps Estimate
-2.1
Earnings History > 10 > eps Difference
-4.8
Earnings History > 10 > surprise Percent
-228.5714
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-30
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.18
Earnings History > 11 > eps Estimate
-0.22
Earnings History > 11 > eps Difference
0.04
Earnings History > 11 > surprise Percent
18.1818
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.12
Earnings History > 12 > eps Estimate
-0.15
Earnings History > 12 > eps Difference
0.03
Earnings History > 12 > surprise Percent
20
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-11
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.05
Earnings History > 13 > eps Estimate
-0.12
Earnings History > 13 > eps Difference
0.07
Earnings History > 13 > surprise Percent
58.3333
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-13
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.07
Earnings History > 14 > eps Estimate
-0.2
Earnings History > 14 > eps Difference
0.13
Earnings History > 14 > surprise Percent
65
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-15
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.05
Earnings History > 15 > eps Estimate
-0.17
Earnings History > 15 > eps Difference
0.12
Earnings History > 15 > surprise Percent
70.5882
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-16
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.17
Earnings History > 16 > eps Estimate
-0.17
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-16
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.07
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-04-15
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.06
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2020-12-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-53.2341
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-09-30
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-194.904
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-06-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-187.9699
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-03-31
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-295.2379
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-30
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.07
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-14
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.08
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-14
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.13
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-14
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.19
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-29
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.38
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-11-16
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.03
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-08-14
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.29
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-04-02
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.06
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2017-12-31
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-2160
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-11-14
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.06
Earnings History > 32 > eps Estimate
-
Earnings History > 32 > eps Difference
0
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-08-08
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
0.02
Earnings History > 33 > eps Estimate
-
Earnings History > 33 > eps Difference
0
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-05-04
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-0.08
Earnings History > 34 > eps Estimate
-
Earnings History > 34 > eps Difference
0
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2016-12-31
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-4523.4413
Earnings History > 35 > eps Estimate
-
Earnings History > 35 > eps Difference
0
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-09-30
Earnings History > 36 > report Date
2016-09-30
Earnings History > 36 > date
2016-09-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-4053.7575
Earnings History > 36 > eps Estimate
-
Earnings History > 36 > eps Difference
0
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-06-30
Earnings History > 37 > report Date
2016-06-30
Earnings History > 37 > date
2016-06-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-4529.4386
Earnings History > 37 > eps Estimate
-
Earnings History > 37 > eps Difference
0
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-03-31
Earnings History > 38 > report Date
2016-03-31
Earnings History > 38 > date
2016-03-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
USD
Earnings History > 38 > eps Actual
-7242.0464
Earnings History > 38 > eps Estimate
-
Earnings History > 38 > eps Difference
0
Earnings History > 38 > surprise Percent
-
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company's NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAug Fed Impact: Is Pixelworks Inc. stock undervalued right now - Earnings Beat & Safe Entry Point Alerts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$22.25
Analyst Picks
Strong Buy
1
Buy
0
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.34% of the total shares of Bone Biologics Corp
1.
Fidelity Extended Market Index(0.1534%)
since
2025/07/31
2.
Spartan Extended Market Index Pool F(0.0865%)
since
2025/07/31
3.
Fidelity Total Market Index(0.0365%)
since
2025/07/31
4.
Fidelity Series Total Market Index(0.0348%)
since
2025/07/31
5.
Tower Research Capital LLC(0.0111%)
since
2025/06/30
6.
CLEAR STREET LLC.(0.0077%)
since
2025/06/30
7.
UBS Group AG(0.0063%)
since
2025/06/30
8.
Bank of America Corp(0.0002%)
since
2025/06/30
9.
Geode Capital Management, LLC(0%)
since
2025/06/30
10.
SBI Securities Co Ltd(0%)
since
2025/06/30
11.
Citigroup Inc(0%)
since
2025/03/31
12.
HRT FINANCIAL LLC(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.37
EPS Estimate
-7.92
EPS Difference
7.55
Surprise Percent
95.3283%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.